Barely Significant
← all excerpts

Measurable residual disease monitoring by ddPCR in the early posttransplant period complements the traditional MFC method to predict relapse after HSCT in AML/MDS: a multicenter retrospective study.

J Transl Med · 2024 · PMC11061929 · PMID 38689269

Europe PMCDOI
1
hedged sentence
0.0670
closest p · 1.3× alpha
0.0670
boldest claim

The sentences

borderline significantP = 0.067so close (0.05 < p ≤ 0.1)
In the external validation cohort, it was observed that MRD-positive patients showed a higher CIR compared to MRD-negative patients ( P = 0.049), and their RFS demonstrated a borderline significant difference compared to MRD-negative patients ( P = 0.067).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.